Mark Engel

Excel PharmaStuduies, Inc. provides regulatory, clinical research and quality assurance services. The firm offers services in the areas of clinical drug development, Phase I~IV, bioequivalence studies, clinical monitoring, project management, patient recruitment, data management, biostatistics analysis, translation, medical report writing, and other related services. The company was founded in 1999 and is located in Beijing, China.

Excel PharmaStuduies, Inc. provides regulatory, clinical research and quality assurance services. The firm offers services in the areas of clinical drug development, Phase I~IV, bioequivalence studies, clinical monitoring, project management, patient recruitment, data management, biostatistics analysis, translation, medical report writing, and other related services. The company was founded in 1999 and is located in Beijing, China.

Phagelux (Canada), Inc. specializes in biological products except diagnostic substances. The firm offers its products for solving bacterial problems in agricultural, food safety, animal health, and topical and inhaled treatments to treat various diseases. The company was incorporated on March 11, 2015 and is headquartered in Toronto, Canada.

Phagelux, Inc. develops anti-bacterial solutions. It specializes across multiple fields utilizing various phage and phage-based technologies and solutions. The company is headquartered in Shanghai, China.

Excel PharmaStuduies, Inc. provides regulatory, clinical research and quality assurance services. The firm offers services in the areas of clinical drug development, Phase I~IV, bioequivalence studies, clinical monitoring, project management, patient recruitment, data management, biostatistics analysis, translation, medical report writing, and other related services. The company was founded in 1999 and is located in Beijing, China.